Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring: Overview and Classification

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Practical Considerations for Prostate Cancer Imaging and Radiopharmaceutical Therapy.

Journal of nuclear medicine technology·2026

Same author

Key Concepts in Prostate Cancer Imaging and Theranostics: A Practical Terminology Guide for Nuclear Medicine Professionals.

Journal of nuclear medicine technology·2026

Same author

Radiology Myth Busters: Debunking Common Radiology Misconceptions.

Radiographics : a review publication of the Radiological Society of North America, Inc·2026

Same author

Prostate Imaging-PET: <sup>18</sup>F-Piflufolastat (Pylarify).

Journal of nuclear medicine technology·2026

Same author

Prostate Imaging-PET: <sup>68</sup>Ga-Gozetotide (Locametz, Illuccix, and Gozellix).

Journal of nuclear medicine technology·2026

Same author

Remarkable response to radiation in a non-enhancing diffuse pediatric-type high-grade glioma with germline <i>ATM</i> mutation: The role of PET imaging and integrated histological and molecular analysis.

Neuro-oncology advances·2026

Same journal

<sup>18</sup>F-NaF PET/CT Versus <sup>18</sup>F-FDG PET/CT for Baseline Mapping in Ollier Disease: A Pediatric Case.

Journal of nuclear medicine technology·2026

Same journal

Incidental Detection of Aggressive HER2-Positive Breast Cancer on <sup>99m</sup>Tc-Sestamibi Parathyroid Scintigraphy.

Journal of nuclear medicine technology·2026

Same journal

Structured Educational Tours in Hospital-Based Radiopharmaceutical Production: Balancing Safety and Learning.

Journal of nuclear medicine technology·2026

Same journal

Development of a Phantom for Evaluating Image Quality and Partial-Volume Effects in Hot and Cold Regions in Small-Animal SPECT and PET.

Journal of nuclear medicine technology·2026

Same journal

Nonuniformity in a Certified <sup>68</sup>Ge PET Cylinder Phantom: Implications for Normalization Quality Assurance.

Journal of nuclear medicine technology·2026

Same journal

Reducing Formation of Suspected Tracer Microemboli During Preparation of <sup>99m</sup>Tc-Tagged Heat-Damaged Red Blood Cells.

Journal of nuclear medicine technology·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 9, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Framing Theranostic Protocols: Development, Implementation, and Insights from Clinical Practice.

Victoria West¹, Elyse Mace Ezra², Mike Nguyen²

¹Molecular Imaging and Therapy, Oregon Health & Science University, Portland, Oregon westv@ohsu.edu.

Journal of Nuclear Medicine Technology

|December 4, 2025

Summary

This summary is machine-generated.

Standardized protocols for theranostic procedures are crucial for technologists. This study details protocol development at Oregon Health & Science University to enhance patient care, training, and workflow reproducibility in theranostics.

Keywords:

clinical practice nuclear medicine technologists protocol development protocol implementation theranostic protocols

More Related Videos

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Related Experiment Videos

Last Updated: Jan 9, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of ⁶⁸Ga-Labelled Nano Molecules

Published on: October 4, 2024

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Enhancing Efficiency and Radiolabeling Yields of Carbon-11 Radioligands for Clinical Research Using the Loop Method

Published on: December 20, 2024

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines

Published on: March 4, 2017

Area of Science:

Nuclear Medicine
Radiopharmaceutical Therapy
Medical Imaging

Background:

Technologists face growing responsibilities in complex theranostic procedures.
Limited formal training and standardized protocols hinder consistent theranostic care.
Need for reproducible workflows in therapy administration and imaging is critical.

Purpose of the Study:

To outline the development and implementation of detailed theranostic protocols.
To support patient care, regulatory compliance, and staff training.
To provide practical examples for institutions expanding theranostic services.

Main Methods:

Collaborative protocol development involving technologists, physicians, nurses, and physicists.
Focus on delineating responsibilities between nursing and technologist staff.
Incorporating flexibility in administration techniques based on patient needs and resources.

Main Results:

Established detailed protocols for therapy administration and imaging.
Ensured adaptability and consistency through interdisciplinary collaboration.
Provided a framework for reproducible theranostic workflows.

Conclusions:

Developed protocols enhance patient care, regulatory compliance, and staff training.
Protocols facilitate reproducible workflows for theranostic procedures.
These examples contribute to broader standardization efforts in theranostics.